|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.22 HKD | +5.17% |
|
+20.79% | -46.49% |
| Mar. 25 | Transcript : Brii Biosciences Limited, 2023 Earnings Call, Mar 25, 2024 | |
| Mar. 22 | Brii Biosciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Brii Biosciences Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 0.617 million compared to CNY 51.63 million a year ago. Net loss was CNY 174.83 million compared to CNY 484.31 million a year ago.
Basic loss per share from continuing operations was CNY 0.24 compared to CNY 0.67 a year ago. Diluted loss per share from continuing operations was CNY 0.24 compared to CNY 0.67 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -46.49% | 108M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
BRII BIOSCIENCES LIMITED 
